Turnaround times for molecular testing of pediatric viral cerebrospinal fluid samples in United Kingdom laboratories
- PMID: 35663004
- PMCID: PMC9134154
- DOI: 10.5409/wjcp.v11.i3.289
Turnaround times for molecular testing of pediatric viral cerebrospinal fluid samples in United Kingdom laboratories
Abstract
Background: Rapid molecular testing has revolutionized the management of suspected viral meningitis and encephalitis by providing an etiological diagnosis in < 90 min with potential to improve outcomes and shorten inpatient stays. However, use of molecular assays can vary widely.
Aim: To evaluate current practice for molecular testing of pediatric cerebrospinal fluid (CSF) samples across the United Kingdom using a structured questionnaire.
Methods: A structured telephone questionnaire survey was conducted between July and August 2020. Data was collected on the availability of viral CSF nucleic acid amplification testing (NAAT), criteria used for testing and turnaround times including the impact of the coronavirus disease 2019 pandemic.
Results: Of 196/212 (92%) microbiology laboratories responded; 63/196 (32%) were excluded from final analysis as they had no on-site microbiology laboratory and outsourced their samples. Of 133 Laboratories included in the study, 47/133 (35%) had onsite facilities for viral CSF NAAT. Hospitals currently undertaking onsite NAAT (n = 47) had much faster turnaround times with 39 centers (83%) providing results in ≤ 24 h as compared to those referring samples to neighboring laboratories (5/86; 6%).
Conclusion: Onsite/near-patient rapid NAAT (including polymerase chain reaction) is recommended wherever possible to optimize patient management in the acute setting.
Keywords: Cerebrospinal fluid; Nucleic acid amplification testing; Questionnaire survey; Turnaround times; Viral studies.
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: None for any of the authors.
Figures
References
-
- Hudson JA, Broad J, Martin NG, Sadarangani M, Galal U, Kelly DF, Pollard AJ, Kadambari S. Outcomes beyond hospital discharge in infants and children with viral meningitis: A systematic review. Rev Med Virol. 2020;30:e2083. - PubMed
-
- Martin NG, Sadarangani M, Pollard AJ, Goldacre MJ. Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study. Lancet Infect Dis. 2014;14:397–405. - PubMed
-
- National Institute for Health and Care Excellence (NICE) Meningitis (bacterial) and meningococcal septicaemia in under 16s: recognition, diagnosis and management. [cited 15 May 2021]. Available from: https://www.nice.org.uk/guidance/cg102 . - PubMed
-
- Turner PC, Brayley J, Downing HC, Homfray GJ, Doolan G, Paul SP. Screening for enteroviral meningitis in infants and children-Is it useful in clinical practice? J Med Virol. 2019;91:1882–1886. - PubMed
LinkOut - more resources
Full Text Sources